Pneumoconiosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Pneumoconiosis}} | {{Pneumoconiosis}} | ||
{{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | {{CMG}}; {{AE}} [[User:Dushka|Dushka Riaz, MD]] | ||
==Overview== | |||
There are no established measures for the secondary prevention of [disease name]. | |||
OR | |||
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Secondary Prevention== | |||
There are no established measures for the secondary prevention of [disease name]. | |||
OR | |||
Effective measures for the secondary prevention of [disease name] include: | |||
*[Strategy 1] | |||
*[Strategy 2] | |||
*[Strategy 3] | |||
==References== | ==References== |
Revision as of 19:35, 26 April 2021
Pneumoconiosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pneumoconiosis secondary prevention On the Web |
American Roentgen Ray Society Images of Pneumoconiosis secondary prevention |
Risk calculators and risk factors for Pneumoconiosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dushka Riaz, MD
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]